Cargando…
RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells
Multidrug resistance (MDR) is a major clinical obstacle in treatment of gastric cancer. Previously, using 2D electrophoresis-mass spectrometry, we identified RhoGDI2 as a contributor to 5-FU resistance in colon cancer cells, and also confer gastric cancer cells resistance to 5-FU. Here, we reported...
Autores principales: | Zheng, Zhong, Liu, Bingya, Wu, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404694/ https://www.ncbi.nlm.nih.gov/pubmed/25901126 http://dx.doi.org/10.1186/s12935-015-0190-4 |
Ejemplares similares
-
RhoGDIα regulates spermatogenesis through Rac1/cofilin/F-actin signaling
por: Zhu, Haixia, et al.
Publicado: (2023) -
Regulation of RhoGTPase crosstalk, degradation and activity by RhoGDI1
por: Boulter, Etienne, et al.
Publicado: (2010) -
PKCα phosphorylation of RhoGDI2 at Ser 31 disrupts interactions with Rac1 and decreases GDI activity
por: Griner, Erin M., et al.
Publicado: (2012) -
Cholecystokinin-Mediated RhoGDI Phosphorylation via PKCα Promotes both RhoA and Rac1 Signaling
por: Sabbatini, Maria Eugenia, et al.
Publicado: (2013) -
Rictor regulates cell migration by suppressing RhoGDI2
por: Agarwal, Nitin K., et al.
Publicado: (2012)